C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer

A. Nebbioso, V. Carafa, M. Conte, F.P. Tambaro, A. Ciro, J. Martens, M. Nees, R. Benedetti, I. Pallavicini, S. Minucci, G. Garcia-Manero, F. Iovino, G. Lania, C. Ingenito, V.B. Petrizzi, H.G. Stunnenberg, L. Altucci

Research output: Contribution to journalArticle

Cite this

Nebbioso, A., Carafa, V., Conte, M., Tambaro, F. P., Ciro, A., Martens, J., Nees, M., Benedetti, R., Pallavicini, I., Minucci, S., Garcia-Manero, G., Iovino, F., Lania, G., Ingenito, C., Petrizzi, V. B., Stunnenberg, H. G., & Altucci, L. (2017). C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer. Clinical Cancer Research, 23(10), 2542-2555. https://doi.org/10.1158/1078-0432.CCR-15-2388